Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 10:55 am Sale | 2022-12-31 | 13G | ADMA Biologics, Inc. ADMA | Stonepine Capital Management LLC | 6,940,000 3.100% | -2,971,577 (-29.98%) | Filing History |
| 2023-02-03 12:10 pm Purchase | 2022-12-31 | 13G | ADMA Biologics, Inc. ADMA | BlackRock Inc. BLK | 15,101,281 6.900% | 9,347,461 (+162.46%) | Filing History |
| 2022-12-09 5:00 pm Sale | 2022-12-09 | 13D | ADMA Biologics, Inc. ADMA | Caligan Partners LP | 10,264,311 4.600% | -628,926 (-5.77%) | Filing History |
| 2022-06-28 4:38 pm Purchase | 2022-06-21 | 13G | ADMA Biologics, Inc. ADMA | MILLENNIUM MANAGEMENT LLC | 6,254,409 3.200% | 6,254,409 (New Position) | Filing History |
| 2022-02-14 8:55 pm Unchanged | 2021-12-31 | 13G | ADMA Biologics, Inc. ADMA | PERCEPTIVE ADVISORS LLC | 11,933,387 6.100% | 0 (Unchanged) | Filing History |
| 2022-02-14 1:52 pm Unchanged | 2020-12-31 | 13G | ADMA Biologics, Inc. ADMA | Consonance Capital Management LP | 1,558,290 1.650% | 0 (Unchanged) | Filing History |
| 2022-02-14 08:21 am Sale | 2021-12-31 | 13G | ADMA Biologics, Inc. ADMA | Stonepine Capital Management LLC | 9,911,577 5.100% | -61,300 (-0.61%) | Filing History |
| 2022-02-11 2:39 pm Purchase | 2021-12-31 | 13G | Terex Corporation TEX | NWQ INVESTMENT MANAGEMENT COMPANY LLC | 10,612,600 5.420% | 10,612,600 (New Position) | Filing History |
| 2022-02-04 08:30 am Purchase | 2022-02-03 | 13D | ADMA Biologics, Inc. ADMA | Caligan Partners LP | 10,893,237 5.600% | 10,893,237 (New Position) | Filing History |
| 2021-12-30 12:26 pm Purchase | 2021-12-28 | 13G | ADMA Biologics, Inc. ADMA | Stonepine Capital Management LLC | 9,972,877 5.100% | 9,972,877 (New Position) | Filing History |
| 2021-10-27 09:16 am Sale | 2021-10-22 | 13G | ADMA Biologics, Inc. ADMA | PERCEPTIVE ADVISORS LLC | 11,933,387 6.600% | -4,651,415 (-28.05%) | Filing History |
| 2021-04-09 6:02 pm Purchase | 2021-03-31 | 13G | ADMA Biologics, Inc. ADMA | BlackRock Inc. BLK | 5,753,820 4.700% | 330,121 (+6.09%) | Filing History |
| 2021-02-16 3:37 pm Purchase | 2020-12-31 | 13G | ADMA Biologics, Inc. ADMA | PERCEPTIVE ADVISORS LLC | 16,584,802 17.500% | 500,000 (+3.11%) | Filing History |
| 2021-02-16 2:11 pm Sale | 2020-12-31 | 13G | ADMA Biologics, Inc. ADMA | Consonance Capital Management LP | 1,558,290 1.650% | -3,608,671 (-69.84%) | Filing History |
| 2021-02-02 2:56 pm Purchase | 2020-12-31 | 13G | ADMA Biologics, Inc. ADMA | BlackRock Inc. BLK | 5,423,699 5.700% | 1,250,938 (+29.98%) | Filing History |